Certara expands PBPK simulator availability

By Melissa Fassbender contact

- Last updated on GMT

Certara expands PBPK simulator availability

Related tags: Pharmacokinetics, Pharmacology

Certara has developed a new licensing approach, which provides smaller organizations access to its physiologically-based pharmacokinetic (PBPK) modeling and simulation platform.

According to the company, Simcyp Access represents a new cloud-based licensing approach for pharmaceutical companies with less than 500 employees.

As Outsorucing-Pharma.com previously reported​, Simcyp helps predict pharmacokinetic outcomes in virtual patient populations.

The most recent version​ of the simulator includes enhanced lung, pediatric, and GI transit models, as well as a new dermal absorption model, and a new report assistant.

In order to access the simulator on a rental basis, users must be previously trained on the platform.

Certara explained employees are considered trained if they have attended a Simcyp Workshop within the past three years.

(Feature image: iStock/Torsakarin)

Related topics: Preclinical Research, Preclinical

Related news

Show more

Related products

show more

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Clear Guidelines for IND/CTA

Clear Guidelines for IND/CTA

Altasciences | 24-Feb-2022 | Technical / White Paper

There are many challenges associated with early drug discovery and development. Advancing your best candidate for regulatory submissions requires a careful...

Follow us

Products

View more

Webinars